Table 2.
Effect of L-carnitine (LC) treatment on nuclear status of mouse oocytes selected by BCB test during IVM
| Group | No. of COCs | Nuclear status | |||
|---|---|---|---|---|---|
| GV n (%) | GVBD and MI n (%) | MII n (%) | Deg. n (%) | ||
| Control | 333 | 19 (3.19 ± 1.28) | 74 (25.63 ± 2.94) | 205 (59.56 ± 3.46)a | 32 (11.27 ± 2.47)a |
| 0.3 mg/ml LC | 325 | 14 (3.60 ± 1.58) | 69 (20.66 ± 2.03) | 231 (73.42 ± 2.63)b | 11 (2.32 ± 0.76)b |
| 0.6 mg/ml LC | 358 | 10 (3.21 ± 1.17) | 71 (21.33 ± 1.84) | 268 (73.44 ± 1.93)b | 7 (1.62 ± 0.74)b |
Data are presented as mean ± SEM. Different superscripts (a, b) within the columns indicate a significant difference (P < 0.01)
COC cumulus oocyte complex, GV germinal vesicle oocyte, GVBD germinal vesicle breakdown, MI metaphase I oocyte, MII metaphase II oocyte, Deg. degenerative oocytes